205 related articles for article (PubMed ID: 19141368)
1. Synthesis and biological evaluation of p-carborane bisphenols and their derivatives: structure-activity relationship for estrogenic activity.
Ogawa T; Ohta K; Iijima T; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2009 Feb; 17(3):1109-17. PubMed ID: 19141368
[TBL] [Abstract][Full Text] [Related]
2. Novel estrogen receptor (ER) modulators: carbamate and thiocarbamate derivatives with m-carborane bisphenol structure.
Ohta K; Ogawa T; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2009 Dec; 17(23):7958-63. PubMed ID: 19857971
[TBL] [Abstract][Full Text] [Related]
3. New estrogenic antagonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.
Endo Y; Yoshimi T; Yamakoshi Y
Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):312-4. PubMed ID: 10705532
[TBL] [Abstract][Full Text] [Related]
4. m-Carborane bisphenol structure as a pharmacophore for selective estrogen receptor modulators.
Ogawa T; Ohta K; Yoshimi T; Yamazaki H; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem Lett; 2006 Aug; 16(15):3943-6. PubMed ID: 16735120
[TBL] [Abstract][Full Text] [Related]
5. Effects of C2-alkylation, N-alkylation, and N,N'-dialkylation on the stability and estrogen receptor interaction of (4R,5S)/(4S,5R)-4,5-bis(4-hydroxyphenyl)-2-imidazolines.
von Rauch M; Schlenk M; Gust R
J Med Chem; 2004 Feb; 47(4):915-27. PubMed ID: 14761193
[TBL] [Abstract][Full Text] [Related]
6. Potent estrogen agonists based on carborane as a hydrophobic skeletal structure. A new medicinal application of boron clusters.
Endo Y; Iijima T; Yamakoshi Y; Fukasawa H; Miyaura C; Inada M; Kubo A; Itai A
Chem Biol; 2001 Apr; 8(4):341-55. PubMed ID: 11325590
[TBL] [Abstract][Full Text] [Related]
7. Estrogenic activity of B-fluorinated o-carborane-1,2-bisphenol synthesized via S(N)Ar reaction.
Ohta K; Ogawa T; Endo Y
Bioorg Med Chem Lett; 2012 Jul; 22(14):4728-30. PubMed ID: 22695130
[TBL] [Abstract][Full Text] [Related]
8. Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta.
Descôteaux C; Leblanc V; Bélanger G; Parent S; Asselin E; Bérubé G
Steroids; 2008 Oct; 73(11):1077-89. PubMed ID: 18572212
[TBL] [Abstract][Full Text] [Related]
9. Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro.
Vessières A; Top S; Pigeon P; Hillard E; Boubeker L; Spera D; Jaouen G
J Med Chem; 2005 Jun; 48(12):3937-40. PubMed ID: 15943467
[TBL] [Abstract][Full Text] [Related]
10. Potent androgen antagonists based on carborane as a hydrophobic core structure.
Fujii S; Goto T; Ohta K; Hashimoto Y; Suzuki T; Ohta S; Endo Y
J Med Chem; 2005 Jul; 48(14):4654-62. PubMed ID: 16000001
[TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of carborane analogues of tamoxifen.
Beer ML; Lemon J; Valliant JF
J Med Chem; 2010 Nov; 53(22):8012-20. PubMed ID: 21028825
[TBL] [Abstract][Full Text] [Related]
12. Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay.
Breinholt V; Larsen JC
Chem Res Toxicol; 1998 Jun; 11(6):622-9. PubMed ID: 9625730
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel m-carborane-containing estrogen receptor partial agonists as SERM candidates.
Ohta K; Ogawa T; Kaise A; Endo Y
Bioorg Med Chem Lett; 2015 Aug; 25(16):3213-6. PubMed ID: 26077489
[TBL] [Abstract][Full Text] [Related]
14. Cobalt-alkyne complexes with imidazoline ligands as estrogenic carriers: synthesis and pharmacological investigations.
Schlenk M; Ott I; Gust R
J Med Chem; 2008 Nov; 51(22):7318-22. PubMed ID: 18942824
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitors based on a thieno[2,3-d]pyrimidin-4(3H)-one core.
Lilienkampf A; Karkola S; Alho-Richmond S; Koskimies P; Johansson N; Huhtinen K; Vihko K; Wähälä K
J Med Chem; 2009 Nov; 52(21):6660-71. PubMed ID: 19824648
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains.
Nguyen A; Top S; Pigeon P; Vessières A; Hillard EA; Plamont MA; Huché M; Rigamonti C; Jaouen G
Chemistry; 2009; 15(3):684-96. PubMed ID: 19053086
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship study to understand the estrogen receptor-dependent gene activation of aryl- and alkyl-substituted 1H-imidazoles.
Wiglenda T; Gust R
J Med Chem; 2007 Apr; 50(7):1475-84. PubMed ID: 17352461
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and estrogenic activity of BODIPY-labeled estradiol conjugates.
Peřina M; Börzsei R; Henrietta Ágoston ; Hlogyik T; Poór M; Rigó R; Özvegy-Laczka C; Batta G; Hetényi C; Vojáčková V; Jorda R; Mernyák E
Eur J Pharm Sci; 2024 Aug; 199():106813. PubMed ID: 38797442
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity study of estrogenic agonists bearing dicarba-closo-dodecaborane. Effect of geometry and separation distance of hydroxyl groups at the ends of molecules.
Endo Y; Iijima T; Amakoshi Y; Kubo A; Itai A
Bioorg Med Chem Lett; 1999 Dec; 9(23):3313-8. PubMed ID: 10612591
[TBL] [Abstract][Full Text] [Related]
20. Increased hydrophobicity and estrogenic activity of simple phenols with silicon and germanium-containing substituents.
Fujii S; Miyajima Y; Masuno H; Kagechika H
J Med Chem; 2013 Jan; 56(1):160-6. PubMed ID: 23214428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
